Ozone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 15, 2025

Study Completion Date

November 20, 2025

Conditions
Oral MucositisOral StomatitisHead and Neck Cancer Squamous Cell CarcinomaRadiotherapy Induced MucositisChemotherapy Induced Mucositis
Interventions
OTHER

Ozone Therapy (In-Office and Home-Based Treatment)

The intervention consists of professional in-office ozone therapy delivered with the Ozono DTA device (Sweden-Martina) applied to oral mucosal lesions. The first treatment is administered at baseline and additional sessions are performed at 48 hours, day 5, day 8, day 12, and day 15, if clinically required. Alongside in-office therapy, participants perform a 15-day domiciliary regimen with ozonated oral care products, including toothpaste with 2% ozonated sunflower oil, a mouthrinse with 4% ozonated sunflower oil solution, and a topical gel with 15% ozonated sunflower oil, each used twice daily. Clinical outcomes are assessed at each visit from baseline to day 15 with the WHO oral mucositis scale and the Visual Analogue Scale for pain.

Trial Locations (1)

27100

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia

All Listed Sponsors
lead

University of Pavia

OTHER